Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings

Core Insights - AngioDynamics, Inc. is expected to report a quarterly loss of 15 cents per share for its first quarter, compared to a loss of 12 cents per share in the same period last year [1] - Projected quarterly revenue for AngioDynamics is $67.93 million [1] - The company received CE Mark approval for its Auryon System in Europe on September 3 [1] - AngioDynamics shares closed at $7.65, reflecting a gain of 0.3% [1] Analyst Ratings - HC Wainwright analyst Yi Chen has a Buy rating with a price target of $14, with an accuracy rate of 63% [2] - Oppenheimer analyst Steven Lichtman upgraded the stock to Outperform with a price target of $12, having an accuracy rate of 74% [2] - Raymond James analyst Jayson Bedford maintained an Outperform rating but reduced the price target from $12 to $10, with an accuracy rate of 71% [2] Consensus Price Target - The consensus price target for AngioDynamics is $12.25 based on ratings from four analysts [3] - The highest price target is $14 from HC Wainwright & Co., while the lowest is $10 from Raymond James [3] - Recent analyst ratings suggest an implied upside of 75.21% for AngioDynamics based on an average price target of $13.67 [3]